In April 2021, the INSEAD Alumni Healthcare Club Switzerland hosted Leading Biopharmaceutical Companies Into The Future After The COVID-19 Crisis. The topic inspired a discussion packed with practical insights on what it takes to manage businesses and keep employees motivated in the face of disruptive forces, systemic change, and ambiguous market environments.
The event featured four panel members: Peter Fang, Corporate SVP/ Global Therapeutic Area Head Inflammation, Boehringer Ingelheim, Michael Puri, Chief Human Resources Officer, Vifor Pharma, Aleksandar Ruzicic, MBA‘97J, Partner, Executive Insight Healthcare Consultants, and Ludger Schwinn, Senior Client Partner, Korn Ferry. It was organized and moderated by Arul Ramadurai, MBA’05J, Healthcare Club Vice-President.
Event Report 20 Apr Swiss Healthcare Club Leading Biopharmaceutical Companies into the Future (pdf)
Executive Insight’s report on Thriving in the post-COVID world in 2021 and beyond.
Slide deck drawing on the Korn Ferry Global Leadership 5.0 Study Future-proofing leadership and the organisations they lead (pdf)